KATHERINE VAZQUEZ: Open Payments
NPI 1962998476 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,896 in 114 payments from 17 companies in 2025. Trend: 2023 $2,268 · 2024 $2,273 · 2025 $3,896
Food & beverage: $3,123Travel & lodging: $719Education: $54
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 5 | $1,071 |
| ABBVIE INC. | 35 | $577 |
| Janssen Biotech, Inc. | 8 | $463 |
| Ardelyx, Inc. | 14 | $358 |
| Madrigal Pharmaceuticals | 5 | $263 |
| Ipsen Biopharmaceuticals, Inc | 9 | $261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $214 |
| Phathom Pharmaceuticals, Inc. | 3 | $171 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $156 |
| GENZYME CORPORATION | 4 | $111 |
Products named: TREMFYA, IBSRELA, RINVOQ, REZDIFFRA, SKYRIZI, VOQUEZNA, XIFAXAN, IQIRVO.
Industry payments across GA — which companies pay providers there.
